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Abstract
NHS England started the work described in this article with the ambition of using insight and feedback from the adult
National Cancer Patient Experience Survey to grow coproduced service improvements leading to improved patient
centred quality outcomes in experience for cancer patients. Based on the Institute for Healthcare Improvement’s
Breakthrough Collaborative Series, the approach of the Cancer Experience of Care Improvement Collaboratives (CIC)
in the English healthcare system was developed, initially with 19 NHS provider organisation teams in 2019 as a face-toface model, then developing into two collaboratives with an additional 15 NHS provider organisation teams in Cohort 2
and 8 teams in Rare & Less Common Cancers in a virtual framework. Each cohort has reported improvements in
patient experience, staff experience and team working, but more fundamentally, have been able to describe a cultural
shift in the way they work, together with people, leaving a lasting impact and legacy of this work. Key learning has been
recognised with the increasing emphasis on involving people with relevant lived experience as partners and colleagues in
the collaborative, alongside flexibility, responsiveness and adaptability as key to enabling project teams to continue where
COVID-19 pressures allowed to participate.

Keywords
Human experience, patient experience, patient centred care, coproduction, patient engagement, quality improvement,
patient and family centred care, measurement, quality of care, workforce engagement

Introduction
The COVID-19 pandemic has created something of a
paradox. Whilst cancer services have been prioritised and
continued to be delivered, other clinical services have
necessarily been paused to varying degrees, leading to
widespread concern about what impact that will have for
individuals who must wait longer for treatment. However,
at the same time, there has been a renewed focus on the
core importance of experience, both in general – not least
The Beryl Institute New Existence1 work– and within
clinical specialities.
The National Health Service (NHS) in England affords, by
the nature of both a systematic planning and delivery
structure (which includes multi-agency Integrated Care
Systems, Cancer Alliances and a regional tier), and a
singular, universal healthcare shared purpose,
opportunities to run national programmes to improve
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people’s experience of healthcare. These programmes
include both the spread of improvement science
methodology for use in any setting (for example, Marshall
C, Zambeaux A, Ainley E et al., 20192) and the continuing
development of focus on improving experience in the
context of clinical transformation programmes.
This is a case study with the main purpose being to
describe the specific and tangible application of practice
for the Cancer Experience of Care Improvement
Collaborative (CIC) approach from initial introduction to
the development of the framework, to create a learning
system for improving the experience of cancer patients in
England. It has been substantially adapted from the
Institute for Healthcare Improvement’s (IHI)
Breakthrough Collaborative Series3 to be deliverable in the
context of the pandemic. The approach has intentionally
put people with relevant lived experience at the centre of
the design and improvement process. There have been
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Figure 1. Three identified key learning points for a successful collaborative

Codesign and Coproduction

• Lived Experience Partners involvement is
a necessity
• Impacts on project success

Impact of Covid

• Flexibility is key to managing project teams
expectations, commitment and progress

Delivery mode

• Virutal delivery provides advantages in
participation, cost and information sharing

three key learning points illustrated in Figure 1, which will
be described in more detail in the subsequent sections.
Steering groups for each cohort made up of relevant
members’ expertise, including those with lived experience,
have been key to success. Other success factors included
regular sessions with the project teams, ad hoc support for
team members and lived experience partners, team visits
(Year 1, face to face and Year 2, virtual), the flexibility,
responsiveness and adaptability of the framework, and
finally the core team and improvement team responding to
and meeting the needs of the project teams on an
individual level. The core team consisted of the

Experience of Care Lead, and Programme Support Officer
from NHS England. Each cohort has reported
improvements in patient experience, staff experience and
team working, but more fundamentally, have been able to
describe a cultural shift in the way they work, together
with people, leaving a lasting impact and legacy of this
work.
In recent years, the NHS in England has increasingly
advocated genuine partnership working with people with
lived experience. A Model for Co-production was
published in 20164 and, in the context of learning lessons
from the pandemic, ‘co-production as default’ has been

Figure 2: Key ambitions for cancer
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adopted nationally as a ‘critical ingredient for change’. This
article also explores how working with people with
relevant lived experience has been embedded in, and had
an impact on, the work of the CIC.

The Issue to Address

The 2019 NHS Long Term Plan5 set out ambitions and
commitments for services and clinical priorities in England
over a ten-year period (Figure 2).
The national Experience of Care Team in NHS England is
responsible for supporting improvement in experience of
care for people using the NHS. The team specifically
supports the NHS Cancer Programme in the ambition to
establish patient experience on a par with clinical
effectiveness and safety.6
The NHS Cancer Programme is responsible for delivering
on the Long-Term Plan for cancer and enables delivery
through 21 Cancer Alliances across England whose role is
to plan effective care across local cancer pathways,
bringing together stakeholders from different
organisations including healthcare and social care to
transform the service for cancer patients to improve
outcomes.
The team wanted to find a way to address the issue of
better supporting cancer service providers taking action to
improve experience of care using available insight and
feedback. There was an opportunity and an appetite to
support NHS healthcare providers directly to focus on
improving experience of cancer care using the National
Cancer Patient Experience Survey (CPES) results.7 The
idea developed to bring together people who, by using
insight and feedback, could grow coproduced quality
improvements to support improved patient experience
outcomes.
There had been previous experience of using the
Improvement Collaborative8 approach in the NHS in
England, for example, in improving frailty and falls
services, and this led to exploration with cancer services.
The improvement science methodology includes the
Model for Improvement8 for defining the aim,
understanding measures and testing change ideas using the
plan, do, study, act cycle for continuous improvement and
sustainability.

This approach was attractive as it had credibility and
structure and there was available capacity and resource
internally to support the work with improvement
expertise. Subsequently, the decision was taken to fund the
first cohort to launch in 2019. The funding covered hire
costs of venues, speaker expenses, accommodation, and
travel costs for steering group lived experience partners.
There continues to be no charge to individual project
teams to join the CIC. They are expected to release staff,
pay travel and accommodation expenses, and reimburse
lived experience partners in line with local policy.
This led to the formation of the initial steering group and
delivery of Cohort 1 for general and all cancers in 20192020, followed by a further two collaboratives in 2020-21
(1. Cohort 2: general and all cancers; and 2. Rare and Less
Common Cancers (RLCC)) which are the focus of this
case study.

Methodology
The methods described in this section include the
practices, and processes applied to enable the success of
the improvement collaborative and why they were
selected.

Overarching Design and Delivery Method

The key elements of the Breakthrough Series (BTS)3
outlined in Figure 3 underpinned the design of the CIC
framework and delivery schedule in all cohorts.
Faculty Selection
In all collaboratives the core team worked with partners to
shape the collaborative aims (Figure 4). Cohort 2 and
RLCC collaborative overarching aims were adapted to
strengthen the focus on coproduction and to align with a
virtual delivery approach due to COVID-19. Therefore,
project teams were asked specifically to recruit a lived
experience partner wherever possible. All collaboratives
developed the relevant delivery and measurement
framework supported by the formation of a steering
group.
The steering group members were selected for expertise in
their field and included representatives from NHS
England both national and regional, Cancer Alliances,
lived experience partners and provider organisations. As a

Figure 3. Key elements of the Breakthrough Series
1
2
3
4
5
6

Topic selection
Faculty recruitment
Enrolment of participating organisations and teams
Learning sessions
Action periods
The model for improvement

Patient Experience Journal, Volume 9, Issue 3 – 2022
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Figure 4. Overarching aims of Cancer Improvement Collaborative
The overall aims of collaboratives were to support organizations to:
Improve the patient experience and quality of care in cancer services by referencing the
Cancer Patient Experience Survey (CPES) results and other insight and feedback to drive
local quality improvements.
Learn about quality improvement tools and techniques and put into practice
Share best practice and innovation resources that are available to providers and participants.
Share learning from the collaborative improvement projects across England
Use learning from the collaborative to inform future CPES survey development.

Strengthened and shift in focus for Cohorts 2 and RLCC aims
•
•
•

Trusts will codesign an improvement project underpinned by improvement science
methodology through learning and application delivered as a virtual programme
Actively promote coproduction and codesign with patient partners included in the
project team
Develop quality improvement skills for the teams taking part through virtual sessions

direct result of learning from Cohort 1, Cohort 2 and
RLCC steering groups expanded to include more members
with lived experience such as having a RLCC, and who
had taken part in Cohort 1, and team members with
improvement skills and knowledge. The purpose was both
to strengthen the expertise and model the principle of
working in coproduction with people with lived experience
from the outset.
Topic Selection
The annual National Cancer Patient Experience Survey 7
(CPES) covers a range of important topics to understand
how care is being experienced. The survey data from
approximately 60,000 respondents is vital in helping NHS
provider organisations to identify the key areas in which
improvements are needed, and to provide a baseline
measure to understand where improvements had been
made. It is not the intention of this article to reproduce
the results of the survey. For each collaborative, themes
were identified by the steering group, based on CPES
results demonstrating a lower-than-average experience of
care (against a high general level of experience), or a
downward trend over time. Applications were welcomed
from provider organisations under these key themes for
improvement (Figure 5). The steering group agreed to
keep the overall aim focused on improving experience of
care allowing flexibility for individual teams to work on
discrete local improvement projects which is different to
the IHI BST Collaborative model whereby a single project
aim is the focus for all.

PEP Health (The Patient Experience Platform9) was
commissioned to understand digital patient voices in near
real time in relation to cancer care. The platform uses
advanced algorithms to collect, sentiment analyse, and rate
comments to form a score on the quality of care. Never
before has digital data from social media been used in this
way to understand what patients are saying about NHS
cancer services. While it is recognized that there are some
limitations to this approach, such as comments being
posted publicly by people who choose to do so, the work
aimed to triangulate with all the other data available to
systems and organisations such as the CPES results,
complaints, the NHS Friends and Family Test,10 cancer
charity surveys, and Care Quality Commission inspection
reports. The outputs from this work show exciting
potential to improve the understanding of what people
say.
Enrolment of participating organisations and teams
In line with previous identified best practice,2 executive
support was required alongside a formal sign-up process to
ensure support and alignment of the improvement
projects with national, regional, and local priorities. Teams
were encouraged to work with lived experience partners as
part of the CIC, and as mentioned earlier this was
strengthened with an expected requirement in Year 2.
There was and continues to be no financial fee to joining
the CIC; however, provider organisations met costs
associated such as time, resources and for Cohort 1, travel,
and accommodation.

As the published CPES data for RLCC must often be
suppressed due to the small numbers of patients,
alternative methods were sought to offer additional
insight.
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Figure 5. Key Themes using insight and feedback
Cohort 1 – All cancers

Home Care and Support
Hospital Inpatient Care
Seeing your General
Practitioner
Overall NHS Care
Other

Cohort 2 - All cancers
Reducing the variation in
experience of care in Black, Asian
and Minority Ethnic communities
and seldom heard groups
Experience of care in Diagnostics
- waiting, communication,
understanding results
Relational aspects of care emotional health and support
including sensitive conversations,
worries and fears and uncertainty
Experience of care for younger
people 16-44
Experience of care with digital
changes
Primary and community services
support

Measurement Framework
Developing a measurement framework with different
types of measures11 (outcome, process, balancing) is key to
ensuring:
• Overall aims of the Collaboratives were met
• Insight and feedback from teams and wider colleagues
is gathered to facilitate continuous improvement and
reflection; utilising the adopt, adapt or abandon
approach
• Tailor the content and delivery of sessions based on
team progress
Cohort measures included the number of project teams
completing the CIC, evaluations of workshops, site visits,
reported changes in staff and patient experience and team
working, reported changes in confidence in using the QI
tools and techniques and improvements in teams using the
IHI Collaborative Assessment Scale12. The scale was
utilised in all collaboratives and subsequently modified for
Year 2 to accommodate the changes to a virtual
framework. It allowed project teams to track their progress
on a scale of 1-5 and was completed before each of the QI
sessions and the end of the collaborative.
All teams were provided with a final evaluation form,
which used Kirkpatrick’s model of evaluation13 and The
Model for Understanding Success in Quality (MUSIQ) 14.
This formed the basis of the evaluation reports which will
be described in the measurable outcomes section.

Rare and Less Common Cancers
Reducing the variation in experience of care in
Black, Asian and Minority Ethnic communities,
Lesbian, Gay, Bisexual, Transgender and
seldom heard groups
Experience of care in Diagnostics - waiting,
communication, understanding results
Relational aspects of care - emotional health
and support including sensitive conversations,
worries and fears and uncertainty
Experience of care for younger people 16-24

Adapting to Delivery during the Pandemic: The
differences in the Delivery of Cohort 2 and Rare and
Less Common Cancers (RLCC)

In Cohort 1 during the improvement cycle (Figure 6), four
in-person events were held for participating teams. These
included presentations from external speakers to share
good practice, opportunities for teams to network and
share their improvement journeys, and taught QI tools and
techniques sessions across a range of themes such as, the
model for improvement, driver diagrams, plan, do, study,
act cycles and sustainability and spread. The improvement
science support was provided by the Clinical Improvement
Project Lead for Nursing, NHS England.
In Year 2, due to capacity issues in the Nursing
Directorate, the Quality Service Improvement Redesign
(QSIR) team part of Mixed Methods, Improvement
Directorate, NHS England provided improvement science
and methodology expertise to co-design the CIC
Framework. The Collaborative Bundle approach was
developed to create a virtually delivered continuous
learning system for project teams in Cohort 2 and RLCC.
There was a change in emphasis for delivery style in the
virtual sessions from teaching improvement methodology,
tools, and techniques to demonstrating application in a
collaborative bundle learning system. This enabled
individual project teams to have protected time together in
the sessions and cross collaborate between other teams to
learn and reflect virtually.
For the CIC to enable teams to apply improvement
science methodology to their projects for sustainable
quality improvement outcomes and to increase team

Patient Experience Journal, Volume 9, Issue 3 – 2022
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Figure 6. Cohort 1 Cancer Experience of Care Improvement Collaborative Design Framework

Figure 7. Cohort 2/RLCC Cancer Improvement Collaborative Design Framework
LAUNCH

Introduction
(Execs &
Project Leads) 2
hours

CLOSE

VIRTUAL delivery totalling 37 hours which excludes
independent work on project progression

Exemplar
Session

Exemplar
Session

Exemplar
Session

Welcome

1 hour

1 hour

1 hour

1 hour

(Project Teams)

QI
workshop
2 hours

QI
workshop
2 hours

QI
workshop
2 hours

QI
workshop
2 hours

Project
Team
Learning

Project
Team
Learning

Project
Team
Learning

Project
Team
Learning

1 hour

1 hour

1 hour

1 hour

1 hour
Working
Together
(Project Team
Leads & Lived
Experience
Partners)
1 hour

Virtual “SITE VISITS” (Max 2
Hrs Each)

COFFEE ROULETTE 30 Minutes x 10

CELEBRATION EVENT(S) 4 hours

Exemplar
Session

INDEPENDENT WORK AND PROJECT PROGRESSION supported by FutureNHS Collaboration Platform & discussion forum
Sept

Oct

Nov

Dec

Jan

Feb

Mar

Sept

“The Cancer Improvement Collaborative (CIC) framework is underpinned by the principles of the IHI Breakthrough Series Collaborative model (ihi.org). The CIC
framework was developed by the QSIR Team, Improvement Directorate, in collaboration with the steering group for the Collaborative led by the Experience of Care
team, Nursing Directorate, NHS England. If redistributing, using for publication or promotion, please acknowledge the origins of this work.”

members confidence in their knowledge and skills, the
design framework (Figure 7) needed the rigour and agility
to create a learning system for participating project teams.
Additionally, sharing learning and outcomes across the
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project teams, with Cancer Alliances and provider
stakeholders, needed to be embedded in the framework, as
it was for Year 1 in person.
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Figure 8. Cancer Collaborative Bundle Sessions

‘The Cancer Improvement Collaborative (CIC) framework is underpinned by the principles of the IHI Breakthrough Series Collaborative
model (ihi.org). The CIC framework was developed by the QSIR Team, Improvement Directorate, in collaboration with the steering group
for the Collaborative led by the Experience of Care team, Nursing Directorate, NHS England. If redistributing, using for publication or
promotion, please acknowledge the origins of this work.’
Each collaborative bundle (Figure 8) was designed to
reflect improvement science methodology tools and
techniques applicable by stage of project in the
programme.
The Exemplar Session included hearing from Cohort 1
teams to reflect on their collaborative experience,
application of improvement science, share lessons learnt
with top tips and current state of their project. The Quality
Improvement workshop focused on specific improvement
science topics such as smart aims, driver diagrams,
measurement framework, statistical process control charts,
facilitated by the QSIR team to demonstrate application of
tools and techniques. Project teams engaged with each
other to apply QI learning to their project in breakout
sessions. The Project Team Sharing & Learning sessions
were facilitated by subject matter experts on a topic area
identified by the project teams from the QI workshop to
engage in a peer discussion and share their learning.
The Cohort 2, RLCC Steering Group members and one
Cohort 2 project lead undertook a mid-point Reflect and
Retrospect workshop facilitated by the NHS England
Knowledge and Evaluation for Improvement (KEI) team.
The discussion, along with a reflective session at the end

Patient Experience Journal, Volume 9, Issue 3 – 2022

of Year 2 generated several recommendations which were
implemented for subsequent years.
Online evaluation using Microsoft Forms (Year 2) was
undertaken at the end of each session to shape and tailor
the content of future sessions. A midpoint survey was
developed, using a similar format to the endpoint survey,
to enable the core team to understand any improvements
made by participating teams over time. Cohort 1 measures
focused more on skills learned. However, there was a
change in focus to applying the knowledge for Year 2
collaboratives. The same survey was repeated at the end of
the collaborative and comparisons drawn between these
results and the midpoint survey.
One of the recommendations from the Reflect and
Retrospect review was to understand the experience of the
lived experience partners in the project teams and offer
them support. An informal drop-in session was held
monthly, led by Steering Group lived experience partners.
A project lived experience partners survey was
implemented at the end of Cohort 2/RLCC CICs as a
means of capturing insight and feedback to improve the
experience of future partners.
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Figure 9. Additional benefits from all cohorts
•
•
•

Building relationships with other teams, trusts reported working closer with IT colleagues, procurement
or communications colleagues which will help future work in the trust;
Sharing learning within cancer alliances;
Networking with other teams across the country and learning from each other’s experiences.

The next section will describe the measurable outcomes
from the programme.

Measurable Outcomes
The measurable outcomes are drawn from the evaluations
of all cohorts, evidence from the visits and the
Celebration/Recognition events. It is difficult to draw
direct comparisons between Year 1 and Year 2 due to the
change in delivery model described above.

Participating Teams

In Cohort 1 seventeen out of 19 trusts completed the
collaborative (89.4%, the target was 90%). Two trusts
withdrew due to resource issues. Fifteen out of the original
21 trusts completed the collaborative in Cohort 2 (71.4%)
and eight out of the original 11 in RLCC (72.7%). This
achievement must be set within the context of the Covid19 pandemic with significant pressures leading to
reprioritisation of resources.
Each project team consisted of approximately 5-7 team
members ranging from clinical staff to support and admin
staff to lived experience partners. The demographics of
the teams were not recorded. It is impossible to know
who responded to the anonymous session evaluations and
surveys and therefore there may be an issue of response
bias in the results.

Overall Measures

Cohort 1 94 % of respondents (n=53) said there was an
improvement in patient or carer experience because of the
collaborative, 96% reported improvements in team
working, and 85% reported improvements in staff
experience of delivering cancer care.
In Cohort 2/RLCC 93% of respondents (n=29) reported
improvements in patient experience, 89% reported staff
experience had improved and 81% reported team working
improvements. Additionally, 100% of respondents would
recommend taking part in the improvement collaborative
to their colleagues.
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In Cohort 1 all the teams were expected to use QI tools
and skills taught with 79% of respondents reporting
improvements in their skills because of the collaborative.
In all cohorts all teams demonstrated improvements in the
Modified IHI Collaborative Assessment Scale.
Coproduction experience varied between teams.
However, through trusts modelling excellent
coproduction, including 15 out of 17 project teams in
Cohort 1 having a lived experience partner on their project
teams, the benefits of the approach were evident. The
teams found the experience enriching and valuable and for
those who already had a strong culture of working with
patients it reinforced the importance of doing so:
“Already empowered to do this. Patient partner input and codesign
was off the scale with this project though which is a really positive
change” Project Team Leader (Cohort 2)
Other benefits cited from all the Cohorts are included in
Figure 9.
Themes from the trust visits (face to face Cohort 1 or
virtual Cohorts 2/RLCC)
Seven key themes were identified (Figure 10) and four of
these are explored in more detail in Figure 11.

Evidence of Local Improvement Projects

Teams worked on different projects under the
collaborative key themes. Figure 12 (See Appendix)
highlights three different teams (one from each
collaborative) and demonstrates their project aim,
measurement framework, change ideas tested and learning
points. This demonstrates the success of the collaborative
model in addressing the original issue.

Outcomes from the perspectives of Key Stakeholders
A key theme that resonates throughout this section on
stakeholder perspectives is co-production. True coproduction happens when different perspectives are not
only articulated but heard. The perspectives of key
stakeholders reflect equal partnerships with communities
in spaces where power is shared, so that services can be
more effective and efficient, and in the long-term more
sustainable.

Patient Experience Journal, Volume 9, Issue 3 – 2022
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Figure 10. Key themes from visits

Use of Data
Framework
and
Methodology

Coproduction
with lived
experience
partners

Visit
Themes

Sustainability
and Spread

Governance

A shift to being empowered begins at the point of
diagnosis, with a collaborative and interactive partnership
between the person living with the disease and their
healthcare team. This CIC gave everyone an opportunity
to change practice and policy and to bring the clinician
closer to the patient experience and the patient closer to
the clinician. It reflected a true insightful experience where
co-production and collective intelligence were fundamental
values; experience of care and how this could be improved
were the unwavering foci.
This insight was a rich seam in the feedback gathered from
the key stakeholders, which included a partner with the
lived experience, a patient facing charity which represented
the voice of people living with a brain tumour, a clinical
nurse specialist, the programme support officer, and a
project team leader. Capturing the learning for individuals
personally gives an added dimension to this case study and
is an important point to support the evidence of
unintended impact of the CIC as well as the overall CIC.
Uncertainty was a key theme, not only about how involved
people with the lived experience would be, but also from
the clinical perspective:
“While I had exposure as a patient partner working locally, this
was a national stage with Trusts represented from all over the
country. So, prior to the event, I was wondering how this would

Patient Experience Journal, Volume 9, Issue 3 – 2022

Staff
engagement

Barriers to
progress

work from a patient’s perspective and how involved they would be.’”
Lived Experience Partner
“This was my first experience working on a national project and
initially I had reservations as I wasn’t sure my clinical experience
would be relevant or wide-ranging enough to be beneficial to this
group.’” Steering group member – clinical nurse specialist
A contributing factor to the uncertainty was the virtual
nature of meetings due to COVID 19 in Year 2.
Implications for social interaction fall within four key
domains: importance of face-to-face meetings in addition
to virtual meetings, trust building, the role of virtual
meetings in maintaining professional relationships and
social agenda issues. The steering group meetings were
virtual, the study days were replaced by Microsoft Teams
enabled sessions which were well-attended and reduced
financial and time costs to the participants.
The insights shared by the key stakeholders revealed how
this uncertainty was addressed. Teamwork was identified
as being a catalyst for change:
“On the project itself, we worked very much as one team and I was
afforded every opportunity to act, not as a rubber stamper of other
people’s ideas, but as a shaper of the initiative.” Lived
Experience Partner
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Figure 11. Four themes in more depth

Framework and
Methodology
•Pace challenging
with difficulty
meeting
deadlines
•Maintained
momentum
•Recordings
online positive
resource to
access (Year 2
only)

•“Being part of the
collaborative really
provided
motivation, focus
and direction”
Project Team
Leader (Cohort
2/RLCC)

Coproduction
•Many teams
successful in
recruiting lived
experience
partners
•Positive and
enriching
experience for
all

Barriers to
progress

•Wider
engagement key
to success

•COVID-19
single largest
barrier with
redeployed staff,
sickness
absence,
operational
pressures all led
to reduced
capacity to
focus

•Engaging at the
right time with
the right staff

•Active partners
in presenting
progress

•Key learning in
reaching out
earlier to
colleagues in IT,
imaging and QI
teams

•“The most
beneficial and
surprising thing
was that we
(patients) all had
similar priorities
for themes for
improvement. It’s
been lovely to
explore those new
ideas in a group
forum” Patient
partner (RLCC)

•“I’ve been a GP
for 35 years and
I’ve never before
seen primary and
secondary care
coming together in
this way...this is
meaningful,
because it is based
on what the
patients are telling
us they need”
Macmillan GP

“Listening to the Lived Experience Partners (LEPs) Network
group share what matters to them, was enlightening and emphasised
the importance of coproduction; we can never assume we know what is
best or what matters most to patients. Working with the LEPs
provided a completely different perspective to navigating the
collaborative, highlighting challenges I had not considered, which
made me realise that there is always more to learn and improve.”
Core Team - Programme Support Officer
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Staff
Engagement

•Cohort 1
barriers were
often outside of
their control
such as IT
servers
•“It’s been a game
changer for me–it’s
changed the way I
feel about working
with patients...It
has just 360
turned and ended
up doing something
else compared to
what we thought we
would do.
Knowing we’re
doing what the
patients need, it’s
been brilliant”
Lead Cancer
Nurse (Cohort 2)

Almost everyone commented on how this project took
people out of their comfort zone (words describing the
initial response to participating included daunting,
challenging, tentative) but as the project developed
participants moved from the comfort zone to the growth
zone. The process of moving zones was not linear and
appreciating that everyone was in the same space helped in
tolerating and reducing uncertainty.
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“The collaborative has challenged me in many ways and often felt
‘behind’ with the added challenge of a global pandemic! Despite this
the project continued due to the enthusiasm of the group; they were
invested and part of the learning from the outset which I feel made
this a success. The experience has brought me out of my comfort zone,
and I have learnt about my leadership strengths and weaknesses.”
Project Team Leader
The sense of collaboration, of building high levels of trust,
of creating collective intelligence were key factors at play
in the success of this project – the openness and
transparency enabled the group to expand the possible:
“There is a sense of pride in being part of a national programme and
cohort of trusts to improve cancer patient experience; supporting and
promoting everyone’s work and networking outside of the
collaborative. The knowledge and skills I have learned have been
invaluable and transferable to other projects I have led.” Project
Team Leader

People with relevant lived experience as partners and
colleagues in the collaborative

“Patients can tell you how the system actually works (not just how it
should work – or how you think it works).” - Ceinwen Giles,
Chair, NHS Cancer Programme Patient & Public Voice
Forum at Cancer Experience of Care Improvement
Collaborative Cohort 1 Launch Event, 1st October 2019
In 2019, at the outset of utilising the collaborative
approach for the improvement of experience in cancer
services there was a clear expectation that people with
relevant lived experience should be involved as partners in
participant organisation’s improvement projects. This was
reflected in inputs at the launch event on ‘patient
experience’ and ‘working with people who use our
services’. However, only a minority of project teams
attending the launch event included someone with lived
experience and, whilst most subsequently recruited lived
experience partners, some teams didn’t.

For those lived experience partners who did participate in
Cohort 1 it was a rewarding experience; they were fully
engaged in the process of co-designing solutions,
providing practical insights into what would work best for
patients and challenging assumptions where necessary.
This, in turn, led to better improvement project ideas,
diversity of patient representation also added a layer of
richness to the initiatives, bringing a range of skills to
complementing those of the health professionals: one
project lead commented that, “this has been so
powerful…because it came from patients.”
For Year 2 it was clear there was a need to do much more
than simply exhort clinical staff to involve patients, when
in most cases they had no experience of doing so. The
steering group recognised that improvements could be
made by including lived experience partners from the
outset. Sessions on co-production with people with lived
experience were run prior to Year 2 launch and the
overarching collaborative objectives explicitly included:
‘Actively promote coproduction and codesign with patient
partners included in the project team’.
Midway through Cohort 2/RLCC programme, a survey of
lived experience partners was undertaken. All respondents
felt they were an equal member of the team and that their
contributions were valued and listened to. The views of
patient partners and project leads on the difference having
lived experience partners made is illustrated above (Figure
13). An informal lived experience partners network forum
was set up in January 2021, to explore common areas of
interest. Three successful events were held, generating lots
of ideas about ways to better involve people, setting
expectations on roles and commitment and how to reach
out and build confidence for partners who have had less
experience of patient involvement.
In addition to the significant part that lived experience
partners have played in project teams, some have also
played leading roles in the launch events and a specific
Cohort 2/RLCC Lived Experience event. All CIC steering

Figure 13. The difference having lived experience partners made
(Quotes taken from the lived experience partner survey and the Cohort 2/RLCC evaluation)
Lived Experience Partners
“Not only hearing the voice of the patients but making
it be the focus from the beginning is really important
and valuable”
“The rewards of being part of a project team which is
focused around improving patient experience are
immense”
“Being involved in the collaborative … gives me a level
of assurance that the changes the team are making are
going to happen”
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Project Leads
“Patient partner input and codesign was off the scale
with this project … which is a really positive change”
“Our service users enlightened us in ways we did not
anticipate’.
“There was no hierarchy, and everyone’s opinion was
valued”

201

NHS Cancer Experience of Care Improvement Collaboratives - A Case Study, Marshall et al.

Figure 14. Coproduction as default
‘Co-production as default’
•
•
•

Always start from what matters most to people who use and work in services
Work with people who have relevant lived experience (patients, service users, unpaid carers and people in
paid lived experience roles) and with staff, in everything we do to directly connect with multiple and
diverse voices
Build equal and reciprocal partnerships with people who have relevant lived experience, and staff,
including with those from disadvantaged and minority communities, from the very start of, and
throughout, all our work.

groups have had two people with relevant lived experience
who have made an equal contribution to multifarious
deliberations, such as on how to better embed lived
experience partners and how to manage the collaborative
in the context of the pandemic. They feel that they have
been able to have a real influence on decision making.
The learning from developing the involvement of people
with lived experience as real partners in the work of the
collaborative has contributed to the thinking behind the
NHS in England recently adopting ‘co-production as
default’ as a ‘critical ingredient for change’ in how learning
from the pandemic should be taken forward. The
expectation across the healthcare system has been
articulated as shown in Figure 14.

Conclusions
There are three main points to highlight from this case
study shown in Figure 15.
The changes made to co-producing with people with
relevant lived experience illustrate how learning lessons
from the way the collaborative has been delivered has been
built into the approach, both year on year and, particularly
in 2020, in year. The first wave of COVID-19 delayed the
start of the collaboratives in spring. The relative hiatus in
the pandemic in the summer of 2020 presented an
opportunity to mobilise the collaboratives in September.
No sooner had the launch taken place COVD-19 cases
and related hospitalisations began to rise again in England,
with significant regional variations, and from the end of
December 2020 the country entered a more extensive
‘wave’ of COVID-19. The operational pressures the
pandemic created for participating healthcare provider

Figure 15. Three key points
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Codesign and Coproduction

• Lived Experience Partners involvement is
a necessity
• Impacts on project success

Impact of Covid

• Flexibility is key to managing project teams
expectations, commitment and progress

Delivery mode

• Virutal delivery provides advantages in
participation, cost and information sharing
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organisations was necessarily, from an early stage,
something the steering group considered and managed.
The guiding principle was to make it clear that judgements
about continued participation were for each organisation
to make, and that there was no national expectation or
pressure, given that the COVID-19 response had to be
everybody’s priority. A supplementary aspect of the
approach was to be flexible in terms of organisation’s
participation status; rather than simply being in or out,
organisations were able to continue participation, pause or
drop-out. This meant that as COVID-19 affected different
parts of the country at different times, teams would be
able to shape their projects and timelines around their
local operational pressures.
Having to make the shift from delivering the collaborative
activities face-to-face to entirely ‘virtual’ delivery had
several unforeseen advantages. Virtual delivery made it
easier for staff and people with lived experience to
participate, removing the need to travel and sessions were
delivered in smaller 1-2 hour ‘bite-sized’ chunks. In
addition, the virtual approach enabled all sessions to be
recorded and uploaded onto a shared online platform for
access at any time.
Flexibility, responsiveness, and adaptability were then key
to enabling project teams to continue, where COVID-19
pressures allowed, to participate. Project teams told us that
staying with the collaborative had enabled a continued
focus on improving experience for cancer patients, despite
COVID-19 operational pressures, and provided them with
some respite from those same pressures. Furthermore, the
learning will be valuable for them in sustaining a focus on
improving experience in the period of ‘recovery’.

Limitations and recommendations for further
improvement
As with the any chosen model there are always limitations
and improvements that can be made in the
implementation and evaluation of the CIC. By the nature
of the CIC, it is a voluntary, optional model and as such
the work is completed with the willing providers of
healthcare. This creates an additional limitation on being
able to spread the outputs of the project teams and share
the learning for implementation country wide without a
mandated national framework.
Although the previous section identified the importance of
the flexible adaptable approach to the virtual delivery, and
the positive benefit of the session recordings being
accessible to all participants 24/7, there is no doubt that
some teams have found the pace of the collaborative
bundles and topics covered in the QI workshops to be
mismatched to their own pace and progress. A
recommendation is to allow the teams more time between

Patient Experience Journal, Volume 9, Issue 3 – 2022

the collaborative bundles to complete work on their
projects. This will be implemented with future cohorts,
extending the time out to 9-10 months of participation.
The CIC approach is also best suited to healthcare systems
who have wider support available within their teams. For
example, those teams who can resource project
management, analytical, experience of care and
improvement science skills appear to be more successful in
completing the CIC and sustaining and spreading their
learning. After expert advice, the core team has decided
not to use the CIC approach for improvement work in
specifically in primary care due to the organisations being
significantly smaller with limited access to the resources
noted above.
The move to the virtual delivery mode has created some
limitations in the ability to network with other teams. The
dedicated FutureNHS collaboration workspace discussion
forum was underutilised, and a Year 2 virtual coffee
roulette for project teams in pairs did little to deliver those
human connections. Teams also reported that although the
virtual sessions were more accessible, they would often be
juggling competing priorities with multiple Microsoft
Teams chat notifications in the background and back-toback meeting schedules leaving little time to process or
reflect on the sessions themselves. These distractions are
often reduced when there is a requirement to physically
travel to a face-to-face event, or protected time is
supported by the executive sponsor. A recommendation
would be to explore a hybrid model of delivery in future
cohorts.
The completion of session evaluation, midpoint and
endpoint surveys has been challenging in the virtual
delivery framework. It is impossible to determine the
sample size, and whether the responses are representative
of the groups’ views or those of a small minority. It is a
recommendation to use a range of methods to seek
feedback to understand experience and impact of the
collaborative. The methods for future cohorts include
using the evaluation forms, deeper dive surveys, project
team leaders 121 meetings, shaping the agendas for the
virtual team visits, and the templates for the Recognition
Events as sources of insight.

Implications for further practice
The CIC has developed in response to the needs of the
healthcare system in the context of a global pandemic.
There have been many learning opportunities, and this
continues with the constant shaping and responding to
both embedding coproduction, and to the changing needs
of the project teams themselves.
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Over the two-year programme, the best practices
previously identified by Marshall C, Zambeaux A, Ainley E
et al in 20192 appear to hold true:

•

1.

In June 2022, NHS England launched Year 4 (Cohort 4)
using insight and feedback from the first ever National
Under 16 Cancer Patient Experience Survey,17 published
in October 2021, to improve experiences of cancer care
for children under 16 and their parents and/or carers. This
will conclude in April 2023.

2.
3.
4.
5.
6.

Partner with people with lived experience from the
very start and throughout every phase
Integrate quality improvement, experience of care and
person-centred care
Identify an executive leader champion who can
support you
Keep an open mind and don’t be tempted to
predetermine what changes need to be made
People who use our services and staff know the
challenges and can co-create change ideas for
improvement
Involve staff from the beginning

The sustainability of the improvements in experience of
care are of the utmost importance. Many of the projects
were still in their infancy when each of the formal
collaboratives ended, but the emphasis on the
collaborative being the beginning of the journey and not
the end holds true. The Experience of Care Team cosponsor, with the charity Macmillan Cancer Support, a
dedicated award at the annual Patient Experience Network
Awards15 focused on using insight and feedback from, for
example the CPES survey, to grow improvements in care
experiences. The purpose is to share learning and shine a
spotlight on examples of good practice. Two of the case
studies included in this article have been award winners.
After this article was originally submitted in 2021, NHS
England launched Year 3 (Cohort 3) in 2021 with the
single focused aim of improving the understandability of
test results for people from ethnically diverse
communities, supporting the reduction of health
inequalities through the Core20PLUS5 approach.16
The participating teams found it restrictive with one aim
and difficulties in identifying baseline data led to some
incompatibility in the pace of the delivery framework
compared to the required slower pace from the teams. As
a result, the overarching aim was not achieved in the
timeframe of the collaborative. This is not to say this
collaborative has not been successful in different ways
with the identification of key learning points and the start
of a cultural shift in organisations addressing the needs
and critical focus of reducing health inequalities.
The 3 key learning points focused on the importance of
•
•

204

Recording accurate ethnicity for cancer services to
understand the experience of specific population
groups
Codesigning and delivering culturally appropriate
services

Using trusted community partners to reach out into
ethnically diverse communities to reduce barriers to
cancer care.
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Appendix
Figure 12. Three case studies of local improvement
Trust

University Hospitals of
Leicester NHS Trust
Cohort 1

East Lancashire Hospitals
NHS Trust
Cohort – Rare and Less
Common Cancers

Northampton General
Hospitals NHS Trust
Cohort 2

Aim Statement

Improve Local Cancer Patient
Experience Survey Results for inpatients to be able to discuss their
worries and fears with staff by 3%

Develop a database of 95% of
Neuroendocrine tumour (NET)
patients by end of Jan 2021 to
improve their experience of care.

Changes
Implemented

• Weekly Information and Support
Rounds on a 19 bedded Oncology
Ward (Weekly as average length of
stay is 5 days)

• Early discussions on the
requirements of the database
with key stakeholders – not
yet implemented. However,
there will need to be ongoing
evaluation of the service, and
the database, to ensure that
there is a quality
improvement in the care,
delivered to NET patients
across the region, and that the
database is fit for purpose.

By February 2021, 76% of
patients with a prostate cancer
diagnosis will report that they
find contacting their Clinical
Nurse Specialist (CNS) easy
• Dedicated contact clinic
Monday-Friday

Cohort

• Information agreed based on most
popular information that is
requested from the Macmillan
Information and Support Centre
and top concerns identified by
patients on completion of their
electronic Holistic Needs
Assessments
• The Oncology Matron and a
Macmillan Patient Information and
Support Officer introduce
themselves to the patients to
provide them with the opportunity
to elicit their worries and fears. The
patients may also help themselves
to a range of information leaflets
and resources from the trolley

• Feedback received from
patient partners led to a
change in direction: The
priority was identified as
increasing the level of
knowledge and understanding
of NETS by generalists.

•

Utilisation of different
media to communicate with
patients

•

Pilot telephone triage
system to sign post patients
to the help they need in a
timely manner

•

Development of
webinars/videos to support
self-management

•

Promotion of other services
to address patient/carer
needs in the form of a
dedicated sticker

• As a result, an additional
system was developed in
conjunction with IT
colleagues, that sends out an
alert whenever a patient with
a NET attends either
Emergency Department or
Medical Assessment Unit –
this means they can be
followed up by the NET
Clinical Nurse Specialist
(CNS) and, thus,
opportunities for sharing
information and knowledge
be facilitated.
• NET CNS commenced in
post
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Appendix (cont’d.)
Figure 12. Three case studies of local improvement (cont’d.)
Trust
Cohort
Process Measures

University Hospitals of
Leicester NHS Trust
Cohort 1

East Lancashire Hospitals
NHS Trust
Cohort – Rare and Less
Common Cancers

Northampton General
Hospitals NHS Trust
Cohort 2

• Number of patients
supported by the ward
round
• Number of ward rounds
that took place

•

A steering group has been
created, meeting monthly
initially and then quarterly,
to ensure the work of the
CNS remain on focus.
Number of patients with
NETS flagged on system in
ED/MAU
Number of patients seen by
NETS CNS
Number of training
sessions delivered (when
education sessions begin)
To understand the impact
of the change idea on the
experience of care a patient
satisfaction survey, based
on a tool used by the Acute
Oncology Team, is being
designed in coproduction
with patient representatives
Repeat qualitative patient
stories
Evaluation of the education
sessions for staff

• Calls answered vs calls to voicemail
for CNS. 45% of contacts were
answered directly by the CNS
Team at baseline

The NET Patient
Administration System
(PAS) Alert system for
emergency admissions has
been implemented at one
Trust site and initial results
are being collected

• 87% (vs 45% baseline) of patients
found it easy or quite easy to
contact their Clinical Nurse
Specialist. 11% reported they did
not need to contact their CNS
because their needs were addressed
through other methods developed
as part of the project
• 100% of patients found the
dedicated information sticker
beneficial
• The most popular method of
contacting the CNS was via mobile
telephone with 58% using this
form of media

•
•
•

Outcome Measures

• Post-ward round patients
complete a survey
supported by a volunteer,
to enable measure the
effectiveness of the
round.

•

•
Balancing Measures

Results

• Staff Experience including
feeling able to manage
difficult conversations
• Staff availability to sustain
the rounds
• Number of patients
unable to complete
questionnaire (end of life
care, in isolation or unable
to complete survey)
• The team implemented
the ward support &
information round and
haven’t been able to
review the national data
set since then due to
COVID-19. However,
the local survey results
demonstrated that 71% of
46 respondents felt that
having the information
and support team
available to talk to had
helped completely or to
some extent.
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•

•

• Number of views of cancer selfmanagement videos + webinars:
Jan 21- 1888
Feb 21 - 2771
Mar 21- 1681
Apr 21 - 1860

• Local patient experience survey –
telephoned 39 patients and asked
% of patients who found it easy or
quite easy to contact their CNS
and identify which change actions
had a positive impact on their
experience and which did not

•

Staff Experience
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Appendix (cont’d.)
Figure 12. Three case studies of local improvement (cont’d.)
Trust
Cohort
Top Tips/Key
Learning

Sustainability and
Rollout
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University Hospitals of
Leicester NHS Trust
Cohort 1
• To keep project principle
simple using SMART
objectives. Project
meetings fortnightly have
led to PDSA cycles of
change
• Patient engagement is key.
Feedback methods from
the team and patients has
altered throughout the
project to capture data
more effectively
• Balancing measure have
helped to address
challenges – the team have
adapted the way we staff
the project
• All eligible patients on day
of round have been
offered opportunity to
discuss their worries and
fears
• Link it with another patient
focused tea trolley teaching
round to facilitate ward
staff to participate across
oncology and haematology
wards.
• Matron cannot attend the
full information and
support round weekly due
to staffing pressures but an
address concerns from
patients around treatment
or in-patient experience at
the end.
• Continue to evaluate
patient feedback as part of
UHL in-patient survey.
• Development of virtual
concept due to changes in
response to COVID-19

East Lancashire Hospitals
NHS Trust
Cohort – Rare and Less
Common Cancers
• Recruit your patient
partners on boards AS
SOON AS POSSIBLE and
LISTEN to them – they
know far more than we
ever could
• Set realistic goals – be
ambitious enough to
motivate everyone but not
so big they are
unachievable
• Be prepared to wait for the
cogs to turn slowly – they
will keep turning

Northampton General Hospitals
NHS Trust
Cohort 2

• The NET Patient PAS
Alert system for emergency
admissions has been
implemented at one Trust
site and if effective will be
rolled out to other Trust
sites.

• The dedicated sticker has been
rolled out to all tumour sites
• Other tumour sites are
expanding the methods by
which patients can contact
them. Other tumour sites teams
now utilising mobile phone
include haematology, secondary
breast, Head & Neck Upper
Gastrointestinal (GI), Skin
Cancer, Gynaecology
• Dedicated telephone triage
system now being piloted in
secondary breast and Upper GI
• Now undertaking “live” patient
experience survey across
different tumour sites to
understand where team are
getting it right for patients and
where there is a need to explore
changes with patients
• Work with teams to roll out the
model to other tumour sites
based on the learning from
pilot - completion September
2021

• Listening to the patient voice is
essential to understand their
individual needs
• Baseline data indicates, the
reason patients contact the
CNS varies with opportunities
to sign post patients directly to
services to meet their individual
needs
• Statistical Process Control
(SPC) chart demonstrates
statistical sustained
improvement in patients being
able to directly contact their
CNS
• Patients like choice in the use
of different media to contact
their CNS
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